Comparative Randomized Trial of Rapamycin versus Paclitaxel-eluting stent in AMI.

Trial Profile

Comparative Randomized Trial of Rapamycin versus Paclitaxel-eluting stent in AMI.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Jul 2017

At a glance

  • Drugs Sirolimus (Primary) ; Paclitaxel
  • Indications Coronary artery disease; Coronary artery restenosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms CEZAR
  • Most Recent Events

    • 16 Sep 2011 Actual end date (1 Dec 2006) added as reported by ISRCTN: Current Controlled Trials.
    • 16 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 30 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by Netherlands Trial Register record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top